Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the ...
Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...
If you’re taking tirzepatide for weight loss, you might find the drug isn’t covered by insurance. It comes with a hefty price tag, which can add up if you take the drug for a long time.